Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current and future prospects for xenotransplantation.

A J French1, J L Greenstein, B E Loveland

  • 1Centre for Early Human Development, Institute of Reproduction and Development, Monash University, Clayton, VIC, Australia. andrew.french@med.monash.edu.au

Reproduction, Fertility, and Development
|December 28, 1999
PubMed
Summary

Xenotransplantation, using pig organs for humans, faces rejection challenges. New strategies modify donor pigs and recipient immunity to improve transplant survival and overcome hyperacute rejection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Methods and applications in computational physiology and medicine.

Frontiers in physiology·2022
Same author

Testicular immune cell populations and macrophage polarisation in adult male mice and the influence of altered activin A levels.

Journal of reproductive immunology·2020
Same author

An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment.

Andrology·2017
Same author

Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set.

Nature communications·2015
Same author

Removal of 3'untranslated sequences dramatically enhances transient expression of ovine follicle-stimulating hormone Beta gene messenger ribonucleic Acid.

Journal of neuroendocrinology·2011
Same author

Interstellar origin of cosmic radiation at radiofrequencies.

Nature·2010

Area of Science:

  • Immunology
  • Transplantation Biology
  • Genetics

Background:

  • Organ shortages drive xenotransplantation research, with pigs as ideal donors.
  • Hyperacute rejection (HAR) is a major barrier to pig-to-human xenografts.
  • Understanding immune responses is key to overcoming xenograft rejection.

Purpose of the Study:

  • To review current strategies for overcoming xenograft rejection.
  • To highlight advancements in genetic modification of donor pigs.
  • To discuss the future of xenotransplantation therapies.

Main Methods:

  • Recipient-directed strategies: immunosuppression, complement inhibition, tolerance induction.
  • Donor-directed strategies: genetic modification (e.g., expressing human proteins, removing alphaGal epitopes).

Related Experiment Videos

  • Advanced breeding techniques: nuclear transfer and cloning for precise gene editing in pigs.

    • Main Results:

    • Experimental xenografts show improved function lasting days to weeks.
    • Transgenic modifications and immune modulation partially overcome HAR and delayed xenograft rejection (DXR).
    • Nuclear transfer enables more efficient and targeted genetic modification of donor pigs.

    Conclusions:

    • Combining donor organ modification, immune tolerance, and novel therapies is crucial for xenograft survival.
    • Targeted gene editing in pigs and understanding immune responses will advance xenotransplantation.
    • Xenotransplantation holds promise for addressing the critical shortage of human donor organs.